The SynGAP Research Fund (SRF) is dedicated to supporting research into SYNGAP1 Encephalopathy, a genetic disorder causing various neurological issues. They aim to fund studies that help understand its clinical aspects, effective therapies, and genetic underpinnings, ultimately advancing knowledge and treatment options for affected individuals.
The grant program by the SynGAP Research Fund awards financial support to young investigators, laboratory-based researchers, and clinicians focusing on SYNGAP1 Encephalopathy. It offers one-year research grants of up to $65,000 and two-year grants of up to $130,000. The funding supports exploration of novel ideas and questions related to the disorder, including its clinical manifestations, potential therapies, and genetic causes. Recipients are required to present their findings at the SynGAP Research Fund’s research roundtable at the American Epilepsy Society the following year. The program explicitly states a policy against the payment of indirect costs to nonprofit institutions.